Impact of gene dosage on gene expression, biological processes and survival in cervical cancer: A genome-wide follow-up study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Medina Martinez, Ingrid ^a   Barrón, Valeria ^a   Roman Bassaure, Edgar ^b   Juárez Torres, Eligia ^a   Guardado Estrada, Mariano ^a   Espinosa, Ana María ^a   Bermudez, Miriam ^a   Fernández, Fernando ^a   Venegas Vega, Carlos ^a   Orozco, Lorena ^c   Zenteno, Edgar ^a   Kofman, Susana ^a   Berumen, Jaime ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; PROTEASOME;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CHROMOSOME 3Q; CHROMOSOME DUPLICATION; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; FOLLOW UP; GENE DOSAGE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME ANALYSIS; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HUMAN CHROMOSOME; HUMAN PAPILLOMAVIRUS TYPE 16; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SURVIVAL; TUMOR GENE; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADULT; AGED; CARCINOGENESIS; CHROMOSOMES, HUMAN; FEMALE; FOLLOW-UP STUDIES; GENE DOSAGE; GENE EXPRESSION PROFILING; GENES, NEOPLASM; GENOMICS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84902302974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097842     Document Type: Article

References (54)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61 (2): 69-90.
2. Yugawa T, Kiyono T (2009) Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19: 97-113.
3. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, et al. (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633-1638.
4. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, et al. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A 107: 18545-18550.
5. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, et al. (1999) Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 24: 144-150. (Pubitemid 29025260)
6. Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, et al. (1997) Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 19: 233-240. (Pubitemid 27330234)
7. Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, et al. (2000) Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 83: 1659-1663. (Pubitemid 32001711)
8. Matthews CP, Shera KA, McDougall JK (2000) Genomic changes and HPV type in cervical carcinoma. Proc Soc Exp Biol Med 223: 316-321. (Pubitemid 30337788)
9. Rao PH, Arias Pulido H, Lu XY, Harris CP, Vargas H, et al. (2004) Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4: 5.
10. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, et al. (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A 93: 479-484. (Pubitemid 26038181)
11. Ried T, Heselmeyer Haddad K, Blegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25: 195-204. (Pubitemid 29266688)
12. Dowen SE, Neutze DM, Pett MR, Cottage A, Stern P, et al. (2003) Amplification of chromosome 5p correlates with increased expression of Skp2 in HPV-immortalized keratinocytes. Oncogene 22: 2531-2540. (Pubitemid 36560735)
13. Mitra AB, Murty VV, Singh V, Li RG, Pratap M, et al. (1995) Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. J Natl Cancer Inst 87: 742-745.
14. Atkin NB (2000) Significance of chromosome 5 and 17 changes in the development of carcinoma of the cervix uteri. Cytogenet Cell Genet 91: 44-46.
15. Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, et al. (2008) Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer 7: 58.
16. Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, et al. (2000) Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 117: 9-18. (Pubitemid 30099648)
17. Adamowicz M, Radlwimmer B, Rieker RJ, Mertens D, Schwarzbach M, et al. (2006) Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer 45: 829-838. (Pubitemid 44182441)
18. Belloni E, Veronesi G, Micucci C, Javan S, Minardi SP, et al. (2011) Genomic characterization of asymptomatic CT-detected lung cancers. Oncogene 30: 1117-1126.
19. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, et al. (2003) Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 36: 233-241. (Pubitemid 36158196)
20. Andersson S, Wallin KL, Hellstrom AC, Morrison LE, Hjerpe A, et al. (2006) Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 95: 331-338. (Pubitemid 44187594)
21. Alameda F, Espinet B, Corzo C, Munoz R, Bellosillo B, et al. (2009) 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases. Hum Pathol 40: 1474-1478.
22. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, et al. (2000) PIK3CA as an oncogene in cervical cancer. Oncogene 19: 2739-2744.
23. Vazquez Mena O, Medina Martinez I, Juárez Torres E, Barrón V, Espinosa A, et al. (2012) Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell Lines. PLOS ONE 7(3): e32667.
24. Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, et al. (2007) Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics 8: 53.
25. Macville M, Schrock E, Padilla Nash H, Keck C, Ghadimi BM, et al. (1999) Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59: 141-150. (Pubitemid 29062970)
26. Wilting SM, de Wilde J, Meijer CJ, Berkhof J, Yi Y, et al. (2008) Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 47: 890-905.
27. Lyng H, Brovig RS, Svendsrud DH, Holm R, Kaalhus O, et al. (2006) Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics 7: 268.
28. Luigi S, Narayan G, Nandula S V, Arias Pulido H, Subramaniyam S, et al. (2008) Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes, Chromosomes and Cancer 47 (9): 755-765.
29. Narayan G, Bourdon V, Chaganti S, Arias Pulido H, Nandula SV, et al. (2007) Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 46: 373-384. (Pubitemid 46411328)
30. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, et al. (2002) Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 33: 98-102.
31. Yuh Cheng Y, Wen Yuann S, Mau Sun C, Yann Jang C, Chi Hung L, et al. (2001) Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genetics and Cytogenetics 131(1): 48-53.
32. Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, et al. (2007) Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 67: 10163-72. (Pubitemid 350070788)
33. Buitrago Pérez A, Garaulet G, Vázquez Carballo A, Paramio JM, García Escudero R (2009) Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling. Current Genomics. 10(1): 26-34.
34. Teissier S, Ben Khalifa J, Mori M, Pautier P, Desaintes C, et al. (2007) New E6/P63 Pathway, Together with a Strong E7/E2F Mitotic Pathway, Modulates the Transcriptome in Cervical Cancer Cells. Journal of virology: 81(17): 9368-9376. (Pubitemid 47311479)
35. Thierry F, Benotmane M, Demeret C, Mori M, Teissier S, et al. (2004). A Genomic Approach Reveals a Novel Mitotic Pathway in Papillomavirus Carcinogenesis. Cancer Res. 64(3): 895-903. (Pubitemid 38176890)
36. Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10: 550-60.
37. Patel D, McCance DJ (2010) Compromised spindle assembly checkpoint due to altered expression of Ubch10 and Cdc20 in human papillomavirus type 16 E6-and E7-expressing keratinocytes. J Virol 84: 10956-64.
38. Johnson RF and Perkins ND (2012) Nuclear factor-κB, p53, and mitochondria: Regulation of cellular metabolism and the Warburg effect. Trends in Biochemical Sciences, 37(8), 317-324.
39. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, and Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6), 1129-1136. (Pubitemid 120035062)
40. Kawauchi K, Araki K, Tobiume K and Tanaka N (2008) p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nature cell biology, 10(5), 611-618. (Pubitemid 351627381)
41. Perkins ND (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nature Reviews Molecular Cell Biology, 8(1), 49-62.
42. Cairns RA, Harris IS and Mak TW (2011) Regulation of cancer cell metabolism. Nature Reviews Cancer, 11(2), 85-95.
43. Shaw RJ (2006). Glucose metabolism and cancer. Current opinion in cell biology, 18(6), 598-608.
44. Parks SK, Chiche J and Pouysségur J (2013) Disrupting proton dynamics and energy metabolism for novel cancer therapy. Nat Rev. 13 (9): 611-623.
45. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105: 103-4.
46. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, et al. (1989) The Use of Polymerase Chain Reaction Amplification for the Detection of Genital Human Papillomaviruses (eds Furth, M. & Greaves, M. F.) 209-214 (Cold Spring Harbor, New York).
47. Van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM (1990) Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 28: 2739-43.
48. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, et al. (1991) Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Cancer Sci 82, 524-531.
49. Guardado Estrada M, Medina Martínez I, Juárez Torres E, Roman Bassaure E, Macías L, et al. (2012) The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J. Hum. Gen 57(4), 269-276.
50. Espinosa AM, Alfaro A, Roman Basaure E, Guardado Estrada M, Palma I, et al. (2013) Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer. PLOS One 8(2): e55975.
51. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121. (Pubitemid 32397092)
52. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
53. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
54. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30(1): 207-10. (Pubitemid 34679544)